PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Jun 15, 2021
Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic Benchmark Data from COPE Program Jun 14, 2021
Traction for Psychedelics: First Psychedelics ETF Comes to the US as Bills Move Forward in California, Texas, and New… Jun 9, 2021
National Institutes of Health Director Praises Psychedelics and Medical Cannabis Research May 31, 2021
PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover… May 27, 2021
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing May 26, 2021
7 Investment Tips from Kevin O’Leary, Who Says There’s More Money In Psychedelics Than There Is In Cannabis May 19, 2021
